Methotrexate vs placebo
Failure to enter remission or possible remission at 16 weeks (Arora 1999) · adult patients with refractory Crohn's disease
Methotrexate showed no clear difference in failure to enter remission or possible remission at 16 weeks (Arora… compared with placebo (low certainty).
1 finding from 1 review
- Methotrexate for induction of remission in refractory Crohn's disease 2014 · Cochrane Headline outcomes onlyRR 3 [0.68, 13.31]1 study · 33 participantsLow